A three-country comparison of psychotropic medication prevalence in youth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The study aims to compare cross-national prevalence of psychotropic medication use in youth. METHODS: A population-based analysis of psychotropic medication use based on administrative claims data for the year 2000 was undertaken for insured enrollees from 3 countries in relation to age group (0-4, 5-9, 10-14, and 15-19), gender, drug subclass pattern and concomitant use. The data include insured youth aged 0-19 in the year 2000 from the Netherlands (n = 110,944), Germany (n = 356,520) and the United States (n = 127,157). RESULTS: The annual prevalence of any psychotropic medication in youth was significantly greater in the US (6.7%) than in the Netherlands (2.9%) and in Germany (2.0%). Antidepressant and stimulant prevalence were 3 or more times greater in the US than in the Netherlands and Germany, while antipsychotic prevalence was 1.5-2.2 times greater. The atypical antipsychotic subclass represented only 5% of antipsychotic use in Germany, but 48% in the Netherlands and 66% in the US. The less commonly used drugs e.g. alpha agonists, lithium and antiparkinsonian agents generally followed the ranking of US>Dutch>German youth with very rare (less than 0.05%) use in Dutch and German youth. Though rarely used, anxiolytics were twice as common in Dutch as in US and German youth. Prescription hypnotics were half as common as anxiolytics in Dutch and US youth and were very uncommon in German youth. Concomitant drug use applied to 19.2% of US youth which was more than double the Dutch use and three times that of German youth. CONCLUSION: Prominent differences in psychotropic medication treatment patterns exist between youth in the US and Western Europe and within Western Europe. Differences in policies regarding direct to consumer drug advertising, government regulatory restrictions, reimbursement policies, diagnostic classification systems, and cultural beliefs regarding the role of medication for emotional and behavioral treatment are likely to account for these differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The rates of increase of pediatric psychotropic drug prescription in the US are alarming (30,34).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The duration of stimulant drug treatment has also greatly increased (34)(35)(36).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Social Transformation of American Medicine
Leavitt, J. W., & Starr, P. (1984) · The American Historical Review · doi:10.2307/1862729 · Cited by 3,247
Basic and Clinical Biostatistics,
(2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00360-0 · Cited by 1,809
McPherson, K., Wennberg, J. E., Hovind, O. B., & Clifford, P. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211183072104 · Cited by 822
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
The Social Transformation of American Medicine
MUELLER, C. B. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390120071024 · Cited by 614
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., & Cantwell, D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11450-7 · Cited by 601
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (2001) · Attention Deficit Hyperactivity Disorders · doi:10.4324/9781315054315-2 · Cited by 572
Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.1.17 · Cited by 526
Self-citationBasic and Clinical Biostatistics
Rosenbaum, S. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460050106033 · Cited by 415
Pharmacoepidemiology and Drug Safety
Mucklow, J. C. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.804.846-b · Cited by 296
Direct Standardization (Age-Adjusted Death Rates): (584012012-001)
Curtin, L. R., & Klein, R. J. (1995) · PsycEXTRA Dataset · doi:10.1037/e584012012-001 · Cited by 251
The Global Market For ADHD Medications
Scheffler, R. M., Hinshaw, S. P., Modrek, S., & Levine, P. (2007) · Health Affairs · doi:10.1377/hlthaff.26.2.450 · Cited by 196
Secular trends in antidepressant prescribing in the UK, 1975-1998
Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.262 · Cited by 168
Increased prescribing trends of paediatric psychotropic medications
Wong, I. C. K. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2004.050468 · Cited by 133
Psychotropic Medication in Children: A Study From The Netherlands
Schirm, E., Tobi, H., Zito, J. M., & de Jong-van den Berg, L. T. W. (2001) · Pediatrics · doi:10.1542/peds.108.2.e25 · Cited by 131
Self-citationMurray, M. L. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2004.064956 · Cited by 119
Antidepressant Use in Children and Adolescents in Germany
Fegert, J. M., Kölch, M. G., ZITO, J. M., Glaeske, G., & Janhsen, K. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.197 · Cited by 105
Self-citationDSM-IV and ICD-10: A Comparison of the Correlates of ADHD and Hyperkinetic Disorder
Tripp, G., Luk, S. L., Schaughency, E. A., & Singh, R. K. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199902000-00014 · Cited by 102
Pediatric Psychopharmacology: Principles and Practice.
Abright, A. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000132814.52288.38 · Cited by 101
Antidepressant prevalence for youths: a multi‐national comparison
Zito, J. M., Tobi, H., de Jong‐van den Berg, L. T. W., Fegert, J. M., Safer, D. J., Janhsen, K., Hansen, D. G., Gardner, J. F., & Glaeske, G. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1254 · Cited by 97
Self-citationPrevalence and patterns of methylphenidate use in French children and adolescents
Knellwolf, A., Deligne, J., Chiarotti, F., Auleley, G.-R., Palmieri, S., Blum‐Boisgard, C., Panei, P., & Autret‐Leca, E. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0401-6 · Cited by 74
Small proportions: what to report for confidence intervals?
Tobi, H., van den Berg, P. B., & de Jong-van den Berg, L. T. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1081 · Cited by 57
Self-citationReferral of Children to Specialists in the United States and the United Kingdom
Forrest, C. B., Majeed, A., Weiner, J. P., Carroll, K., & Bindman, A. B. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.3.279 · Cited by 54
An international perspective on pediatric psychopharmacology
Vitiello, B. (2008) · International Review of Psychiatry · doi:10.1080/09540260801887710 · Cited by 51
Hugtenburg, J. G., Heerdink, E. R., & Egberts, T. C. G. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0765-9 · Cited by 50
Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002
Mancini, J., Thirion, X., Masut, A., Saillard, C., Pradel, V., Romain, F., Pastor, M. J., Coudert, C., & Micallef, J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1258 · Cited by 48
Byck, G. R. (2000) · PEDIATRICS · doi:10.1542/peds.106.1.14 · Cited by 45
CAESAREAN SECTION FOR DYSTOCIA: A COMPARISON OF PRACTICES IN TWO COUNTRIES
Sheehan, K. H. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90185-1 · Cited by 42
Criado‐Álvarez, J. J., & Barrientos, C. R. (2003) · Revista de Neurología · doi:10.33588/rn.3709.2003366 · Cited by 36
Schmidt-Troschke, S., Ostermann, T., Melcher, D., Schuster, R., Erben, C. M., & Matthiessen, P. F. (2004) · Das Gesundheitswesen · doi:10.1055/s-2004-813322 · Cited by 33
Pediatric Psychopharmacology: Principles and Practice (2003)
Steevens, E. C. (2003) · Issues in Mental Health Nursing · doi:10.1080/mhn.24.8.829.831 · Cited by 31
Paediatric methylphenidate (Ritalin®) restrictive conditions of prescription in France
Frances, C., Hoizey, G., Millart, H. G., & Trenque, T. C. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01943.x · Cited by 27
A Comparison of Ambulatory Test Ordering for Hypertensive Patients in the United States and England
Epstein, A. M., Hartley, R. M., Charlton, J. R., Harris, C. M., Jarman, B., & McNeil, B. J. (1984) · JAMA · doi:10.1001/jama.1984.03350130037031 · Cited by 27
Datapoints: Treatment of Attention-Deficit Hyperactivity Disorder by Different Physician Specialties
Zarin, D. A., Tanielian, T., Suarez, A. P., & Marcus, S. C. (1998) · Psychiatric Services · doi:10.1176/ps.49.2.171 · Cited by 27
Holtmann, M. H., Bölte, S., & Poustka, F. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.477 · Cited by 25
Andretta, M., Ciuna, A., Corbari, L., Cipriani, A., & Barbui, C. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0852-y · Cited by 24
World wide use of psychotropic drugs in child and adolescent psychiatric disorders
SIMEON, J. G., Wiggins, D. M., & Williams, E. C. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00026-r · Cited by 24
Increase in non-evidence based use of antidepressants in children is cause for concern
Clavenna, A., Bonati, M. R., Rossi, E., & Rosa, M. D. (2004) · BMJ · doi:10.1136/bmj.328.7441.711-c · Cited by 21
Pediatric Psychopharmacology: Principles and Practice
Varley, C. K., & Calinoiu, I. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.1035-b · Cited by 18
Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., & Wilson, J. P. (2005) · Medical Care · doi:10.1097/01.mlr.0000189036.11725.a6 · Cited by 16
Quality Of Care For Coronary Heart Disease In Two Countries
Ayanian, J. Z., & Quinn, T. J. (2001) · Health Affairs · doi:10.1377/hlthaff.20.3.55 · Cited by 13
Journal of Child and Adolescent Psychopharmacology
&NA; (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000314050.69221.97 · Cited by 12
Worrying Patterns of Out-Patient Psychotropic Drug Prescribing in Children and Adolescents
Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000084005 · Cited by 11
Pharmacoepidemiology and drug safety
(2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.546 · Cited by 11
Life table methods applied to use of medical care and of prescription drugs in early childhood.
Rasmussen, F. E., & Smedby, B. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.2.140 · Cited by 9
A comparison of ambulatory test ordering for hypertensive patients in the United States and England
Epstein, A. M. (1984) · JAMA · doi:10.1001/jama.252.13.1723 · Cited by 4
Pediatric Referral Patterns—Reply
Forrest, C. B. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.1033-b
Research works printed but not linked: 2
- Chiang CL: Standard error of the age-adjusted death rate. US Dept HEW: Vital Statistics Special Reports. 1961, 47: 271-285.
- Zito JM, Safer DJ, Fegert JM, Tobi H, Janhsen K, Glaeske G, Menis M, Ryu J: Neuroleptic prevalence for youths: a multi-national comparison. Poster presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry Toronto. 2005
Cited by
(2013) · PubMed · Cited by 770
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.w770 · Cited by 268
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Treatment of Young People With Antipsychotic Medications in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0500 · Cited by 249
Vitiello, B., Correll, C., van Zwieten-Boot, B., Zuddas, A., Parellada, M., & Arango, C. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.04.008 · Cited by 222
Metadata
- Authors
- Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- University of Groningen (NL)
- University of Bremen (DE)
- Corresponding author
- Zito, Julie M
- Venue
- Child and Adolescent Psychiatry and Mental Health
- Published
- 2008-09-25
- Volume
- 2
- Issue
- 1
- Pages
- 26-26
- ISSN
- 1753-2000 (ISSN-L)
- PMC
- PMC2569908
- OpenAlex
- W1996815465
- Cited by
- 201
- References
- 46
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 13 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 13 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 25 · 2012: 21
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Child and Adolescent Psychiatry and Mental Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- psychotropic drugs, youth, cross-national comparison, antidepressants, stimulants, antipsychotic drugs, atypical antipsychotics, anxiolytics, concomitant drug use, drug use prevalence, health policy, Netherlands, Germany, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.